{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:13:44Z","timestamp":1790648024904,"version":"4.1.0"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>In this study, our objective was to provide practice recommendations by thoroughly examining lifestyle interventions for adults diagnosed with metabolic dysfunction-associated steatotic liver disease (MASLD). This was achieved through a systematic review of the literature, specifically focusing on lifestyle modification interventions in adults with MASLD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The PIPOST (Population, Intervention, Professional, Outcome, Setting, and Type of evidence) framework was used to identify the questions for summarizing evidence. Utilizing the 6S model for the hierarchy of evidence, a computerized search was conducted to retrieve articles pertaining to lifestyle interventions for adults with MASLD from websites such as the UpToDate Clinical Advisor, BMJ Best Practice, JBI Library, Cochrane Library, International Guidelines Library, and PubMed, among others. The available research included clinical decisions, clinical practice guidelines, evidence summaries, systematic evaluation, expert consensus, and expert opinions. Two researchers independently evaluated the methodology of the studies, and evidence was subsequently extracted and grouped thematically. Our review encompassed publications from January 2018 to March 2023.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 26 publications were identified for the final review, consisting of seven guidelines, nine systematic evaluations, and 10 expert consensuses\/opinions. From these sources, we derived six themes, 28 pieces of evidence: intervention modalities, diet management, exercise management, weight loss management, personalized management, and multidisciplinary collaboration.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In the management of adults with MASLD, healthcare professionals should embrace a multidisciplinary team approach, adhere to the best available evidence, and develop structured and personalized interventions based on the best evidence for lifestyle modifications.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnut.2024.1421386","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T04:18:41Z","timestamp":1736137121000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Evidence summary of lifestyle interventions in adults with metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.3389","volume":"11","author":[{"given":"Mei-jing","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-qing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-ying","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,6]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1016\/j.jhep.2023.07.021","article-title":"Can we use old NAFLD data under the new MASLD definition?","volume":"80","author":"Song","year":"2023","journal-title":"J Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.jhep.2021.10.025","article-title":"The global NAFLD policy review and preparedness index: are countries ready to address this silent public health challenge?","volume":"76","author":"Lazarus","year":"2022","journal-title":"J Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"20420188231160394","DOI":"10.1177\/20420188231160394","article-title":"Non-pharmacological management options for MASLD: a practical guide","volume":"14","author":"Stefano","year":"2023","journal-title":"Ther Adv Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e15347","DOI":"10.1016\/j.heliyon.2023.e15347","article-title":"Therapeutic potential of bioactive phytoconstituents found in fruits in the treatment of non-alcoholic fatty liver disease: a comprehensive review","volume":"9","author":"Pathak","year":"2023","journal-title":"Heliyon"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.14744\/hf.2021.2021.0014","article-title":"Sustainability of diet-based moderate calorie restriction among obese patients with metabolic-associated fatty liver disease","volume":"2","author":"Guveli","year":"2021","journal-title":"Hepatol Forum"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.3390\/antiox12071318","article-title":"Adherence to Mediterranean diet: any association with NAFLD?","volume":"12","author":"Barrea","year":"2023","journal-title":"Antioxidants"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1225946","DOI":"10.3389\/fnut.2023.1225946","article-title":"Mediterranean diet affects the metabolic outcome of metabolic dysfunction-associated fatty liver disease","volume":"10","author":"Xiao","year":"2023","journal-title":"Front Nutr"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1439473","DOI":"10.3389\/fnut.2024.1439473","article-title":"Effect of 5:2 intermittent fasting diet versus daily calorie restriction eating on metabolic-associated fatty liver disease-a randomized controlled trial","volume":"11","author":"Wang","year":"2024","journal-title":"Front Nutr"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.3390\/biomedicines9121853","article-title":"The role of physical activity in nonalcoholic and metabolic dysfunction associated fatty liver disease","volume":"9","author":"von Loeffelholz","year":"2021","journal-title":"Biomedicines"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.16821\/j.cnki.hsjx.2020.09.008","article-title":"Promoting the transformation of evidence to clinical practice: research topic selection and problem construction","volume":"35","author":"Zhu","year":"2020","journal-title":"J Nurses Train"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3969\/j.issn.1671-8283.2022.06.011","article-title":"Best evidence for lifestyle management in elderly patients with hypertension","volume":"6","author":"Li","year":"2022","journal-title":"Modern Clin Nurs"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"99.2","DOI":"10.1136\/ebn.12.4.99-b","article-title":"Accessing pre-appraised evidence: fine-tuning the 5S model into a 6S model","volume":"12","author":"Dicenso","year":"2009","journal-title":"Evid Based Nurs"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ypmed.2010.08.005","article-title":"AGREE next steps consortium. AGREE II: advancing guideline development, reporting, and evaluation in health care","volume":"51","author":"Brouwers","year":"2010","journal-title":"Prev Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/jebm.12141","article-title":"The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review","volume":"8","author":"Zeng","year":"2015","journal-title":"J Evid Based Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3969\/j.issn.1672-1756.2020.12.016","article-title":"Evidence summary of safe infant sleeping environment for the prevention of sudden infant death syndrome","volume":"20","author":"Xing","year":"2020","journal-title":"Chinese Nurs Manag"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"key":"ref21","volume-title":"Supporting document for the j oanna briggs institute levels of evidence and grades of recommendation[EB\/OL]","year":"2014"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1007\/s40519-021-01287-1","article-title":"Non-alcoholic fatty liver disease in adults 2021: a clinical practice guideline of the Italian Association for the Study of the liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)","volume":"27","year":"","journal-title":"Eat Weight Disord"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.gastrohep.2017.12.003","article-title":"Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline","volume":"41","author":"Aller","year":"2018","journal-title":"Gastroenterol Hepatol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.eprac.2022.03.010","article-title":"American Association of Clinical Endocrinology Clinical Practice Guideline for the diagnosis and Management of Nonalcoholic Fatty Liver Disease in primary care and endocrinology clinical settings: co-sponsored by the American Association for the Study of Liver Diseases (AASLD)","volume":"28","author":"Cusi","year":"2022","journal-title":"Endocr Pract"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","article-title":"The Asian Pacific Association for the Study of the liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease","volume":"14","author":"Eslam","year":"2020","journal-title":"Hepatol Int"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3350\/cmh.2021.0178","article-title":"KASL clinical practice guidelines: management of nonalcoholic fatty liver disease","volume":"27","author":"Kang","year":"2021","journal-title":"Clin Mol Hepatol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3969\/j.issn.1672-5069.2018.02.007","article-title":"Guidelines of prevention and treatment for nonalcoholic fatty liver disease: a 2018 update","volume":"21","author":"Fan","year":"2018","journal-title":"J Pract Hepatol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/sjg.sjg_357_21","article-title":"The Egyptian clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease","volume":"28","author":"Fouad","year":"2022","journal-title":"Saudi J Gastroenterol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.3390\/nu13093135","article-title":"Positive effects of exercise intervention without weight loss and dietary changes in NAFLD-related clinical parameters: a systematic review and meta-analysis","volume":"13","author":"Babu","year":"2021","journal-title":"Nutrients"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1081096","DOI":"10.3389\/fendo.2023.1081096","article-title":"Effects of lifestyle intervention on adults with metabolic associated fatty liver disease: a systematic review and meta-analysis","volume":"14","author":"Chai","year":"2023","journal-title":"Front Endocrinol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"e0263931","DOI":"10.1371\/journal.pone.0263931","article-title":"Lifestyle changes in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"17","author":"Fern\u00e1ndez","year":"2022","journal-title":"PLoS One"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1055\/a-1742-4257","article-title":"Efficacy of aerobic and resistance exercises in improving visceral adipose in patients with non-alcoholic fatty liver: a meta-analysis of randomized controlled trials","volume":"60","author":"Fu","year":"2022","journal-title":"Z Gastroenterol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1093\/nutrit\/nuaa146","article-title":"Effect of dietary carbohydrate and lipid modification on clinical and anthropometric parameters in nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"79","author":"Garc\u00eaz","year":"2021","journal-title":"Nutr Rev"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"894044","DOI":"10.3389\/fphys.2022.894044","article-title":"Effect of exercise training on serum transaminases in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"13","author":"Hong","year":"2022","journal-title":"Front Physiol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/nutrit\/nuz029","article-title":"Effect of dietary intervention, with or without co-interventions, on inflammatory markers in patients with nonalcoholic fatty liver disease: a systematic literature review","volume":"77","author":"Reddy","year":"2019","journal-title":"Nutr Rev"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.3390\/jcm10081659","article-title":"Evidence-based aerobic exercise training in metabolic-associated fatty liver disease: systematic review with meta-analysis","volume":"10","author":"S\u0142omko","year":"2021","journal-title":"J Clin Med"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.3390\/ijerph18063242","article-title":"Effect of different exercise methods on non-alcoholic fatty liver disease: a meta-analysis and meta-regression","volume":"18","author":"Xiong","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","article-title":"Advancing the global public health agenda for NAFLD: a consensus statement","volume":"19","author":"Lazarus","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3760\/cma.j.issn.1000-6699.2018.07.004","article-title":"Consensus on the diagnosis and treatment of non-alcoholic fat liver disease and related metabolic disorders (second edition)","volume":"34","year":"2018","journal-title":"Chinese J Endocrinol Metab"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"531","DOI":"10.15537\/smj.2019.6.23980","article-title":"Position statement on the diagnosis and management of non-alcoholic fatty liver disease","volume":"40","author":"Alswat","year":"2019","journal-title":"Saudi Med J"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.rgmx.2018.11.007","volume":"84","author":"Bernal-Reyes","year":"2019","journal-title":"Rev Gastroenterol Mex"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/jgh.15787","article-title":"Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction-associated fatty liver disease","volume":"37","author":"Chan","year":"2022","journal-title":"J Gastroenterol Hepatol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/TP.0000000000002483","article-title":"Recommendations for management and treatment of nonalcoholic Steatohepatitis","volume":"103","author":"Ratziu","year":"2019","journal-title":"Transplantation"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1053\/j.gastro.2020.11.051","article-title":"AGA clinical practice update on lifestyle modification using diet and exercise to achieve weight loss in the management of nonalcoholic fatty liver disease: expert review","volume":"160","author":"Younossi","year":"2021","journal-title":"Gastroenterology"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1093\/advances\/nmx007","article-title":"Practical dietary recommendations for the prevention and management of nonalcoholic fatty liver disease in adults","volume":"9","author":"George","year":"2018","journal-title":"Adv Nutr"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s00535-021-01833-9","article-title":"Clinical practice advice on lifestyle modification in the management of nonalcoholic fatty liver disease in Japan: an expert review","volume":"56","author":"Kamada","year":"2021","journal-title":"J Gastroenterol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1016\/j.cgh.2021.01.023","article-title":"Weight loss and weight regain in usual clinical practice: results from the TARGET-NASH observational cohort","volume":"20","author":"Malespin","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s12072-024-10663-9","article-title":"Lifestyle intervention for metabolic dysfunction-associated fatty liver disease: a 24-h integrated behavior perspective","volume":"18","author":"Keating","year":"2024","journal-title":"Hepatol Int"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2024.1421386\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T04:18:50Z","timestamp":1736137130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2024.1421386\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,6]]},"references-count":50,"alternative-id":["10.3389\/fnut.2024.1421386"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2024.1421386","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,6]]},"article-number":"1421386"}}